About 87.5% of patients treated with the drug were alive after six years, compared to 83.2% who received a placebo.

MSD has spent €500M acquiring a Dundalk vaccine plant and several other facilities around Ireland in an early year boost for ...

Merck on Wednesday said it has snagged the rights to an experimental weight loss pill from Chinese drugmaker Hansoh Pharma, in a deal worth up to $2 billion. Merck will pay Hansoh $112 million upfront ...

Merck & Co. has made its first big move in obesity treatment, announcing Wednesday it is paying Hansoh Pharma $112 million for rights outside China to a preclinical pill that works similarly to ...

Lesley spent more than four years at Merck & Co. (NYSE ... some of the clinical collaborations you can get, particularly in Boston. That is a big driver. Boston and San Francisco both have ...

Johnson & Johnson will pay $2 billion to acquire Ambrx while Merck agreed to pay $680 million ... In other deals, medtech player Boston Scientific is coughing up $3.7 billion for Axonics.

Merck & Co. Inc.’s reported positive results Tuesday for a new, easier-to-administer formulation of its blockbuster cancer drug Keytruda. Rahway, N.J.-based Merck MRK said a trial of the drug ...

Merck's DOR/ISL regimen demonstrated non-inferiority to bART and BIC/FTC/TAF in two pivotal Phase 3 trials for adults with HIV-1. Both trials achieved primary safety objectives, with detailed ...

Founded in 2010, the provider of sales enablement software says it works with brands like Nike, AT&T, Prudential and Merck. The Boston-based tech company (Nasdaq: BCOV) is being bought by Bending ...

BOSTON--(BUSINESS WIRE)--EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the appointment of Miguel Fernández Alcalde as President of EMD ...

The drug, according to Merck, is the first and only PARP inhibitor—a type of medication that “causes a disruption in the way that [patients’] cells work,” Marks explains—to improve ...

Merck on Wednesday said it has snagged the rights to an experimental weight loss pill from Chinese drugmaker Hansoh Pharma, in a deal worth up to $2 billion. Merck will pay Hansoh $112 million ...